New drug duo tested in fight against aggressive blood disorder
NCT ID NCT03564873
Summary
This study is testing a combination of two drugs, omacetaxine and azacitidine, for people newly diagnosed with a high-risk type of bone marrow disorder called myelodysplastic syndrome (MDS). The first part of the study aims to find the safest and most effective dose of the combination. The second part will use that dose to see how well it works to control the disease and keep it from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universtiy of Colorado Denver
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.